- The company has appointed veteran medtech finance executive Sarah M. Romano as Chief Financial Officer, effective August 3, 2026.
- Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised more than $100 million during her career.
- The appointment comes as SS Innovations continues pursuing U.S. FDA clearance for its SSi Mantra surgical robotic system while expanding internationally.
- The company recently graduated the inaugural class of its SS International Centre for Robotics Surgery (“SSICRS”) cardiac robotic surgery training program.
- SSICRS welcomed 33 healthcare professionals from seven countries, underscoring the company’s emphasis on surgeon education alongside technology deployment.
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has appointed veteran medical technology finance executive Sarah M. Romano as chief financial officer, adding public-company financial and capital markets experience as the surgical robotics developer continues its global expansion and advances regulatory initiatives. The appointment, effective August 3, comes at a time when SS Innovations is pursuing broader commercialization of its SSi Mantra robotic surgical platform while continuing preparations for U.S. Food and Drug Administration review (https://ibn.fm/91YyY).
Romano joins SS Innovations after serving as chief financial officer at Vicarious Surgical, another developer of robotic surgical technologies, where she oversaw financial and operational initiatives designed to reduce cash burn, strengthen the company’s balance sheet and support strategic growth objectives.
Earlier executive roles included chief financial officer positions at Entero Therapeutics and Kiora Pharmaceuticals, where she managed capital raises, SEC reporting, investor relations and strategic transactions.
According to the company, Romano has raised more than $100 million through public and private financings during her career and brings experience working with emerging public companies navigating periods of operational growth and capital formation.
The appointment reflects a common step among expanding medical technology companies seeking to strengthen financial leadership as commercialization efforts become increasingly complex. The company says Romano’s experience in public-company operations and capital markets will support its ongoing expansion as it works toward broader global adoption of the SSi Mantra surgical robotic system, a platform designed to provide robotic-assisted surgical capabilities across multiple specialties while emphasizing affordability and accessibility.
“We are thrilled to welcome Sarah as our Chief Financial Officer at this critical moment in our growth journey. As we continue our global expansion, including pursuing U.S. FDA approval of our advanced, cost-effective SSi Mantra surgical robotic system, Sarah brings strong financial leadership, keen strategic vision, and extensive capital markets experience,” said Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations. “She will play an integral role in scaling and enhancing our financial operations to accommodate our anticipated growth.”
The leadership addition follows another milestone announced earlier this month that highlights a different aspect of the company’s growth strategy. On July 7, SS Innovations announced that its subsidiary, the SS International Centre for Robotics Surgery (“SSICRS”), graduated the inaugural class of its Cardiac Robotic Surgery Training program (https://ibn.fm/7twsV).
The five-day program brought together 33 healthcare professionals from seven countries for classroom instruction, live surgical demonstrations and hands-on robotic training using the SSi Mantra system. Training focused on robotic-assisted cardiac procedures, including totally endoscopic coronary artery bypass surgery, mitral valve surgery, atrial septal defect repair and related cardiac interventions.
The curriculum combined lectures, laboratory sessions, virtual instruction, scientific discussions and live case observations to familiarize participants with robotic-assisted cardiac techniques. Faculty members included internationally recognized cardiac surgeons from leading institutions in the United States, Belgium and South Korea, reflecting the company’s effort to establish an international education platform alongside its commercial operations.
SSICRS plans to expand beyond cardiac surgery by offering condensed training programs covering additional specialties, including urology, gynecology, thoracic surgery, colorectal procedures, gastrointestinal surgery and general surgery. The training center also incorporates online educational modules that complement in-person instruction through recorded lectures, assessments and continuing educational support.
SS Innovations’ strategy combines technology development with physician training infrastructure intended to support long-term clinical utilization. The company’s broader business centers on its proprietary SSi Mantra robotic surgery platform and the complementary SSi Mudra surgical instruments.
The system supports a variety of minimally invasive surgical procedures, including cardiac surgery, and has increasingly attracted attention for its work in robotic telesurgery. As of June 2026, the company reported that more than 20 cardiac telesurgeries had been successfully performed using the SSi Mantra platform. While telesurgery remains an emerging field rather than the company’s primary commercial focus, the procedures demonstrate technical capabilities that may contribute to future development opportunities.
For more information, visit the company’s website at www.SSInnovations.com.
NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII
About QualityStocks
QualityStocks (“QS”) is a specialized communications platform with a focus on private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, QS is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, QS brings its clients unparalleled recognition and brand awareness. QS is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-published: https://www.QualityStocks.com/Disclaimer
QualityStocks
Austin, Texas
www.QualityStocks.com
512.354.7000 Office
Editor@QualityStocks.com
QualityStocks is powered by IBN
